The epidemiology of dementia associated with Parkinson disease
- PMID: 19733364
- DOI: 10.1016/j.jns.2009.08.034
The epidemiology of dementia associated with Parkinson disease
Abstract
Several recent studies have shown that dementia is common in Parkinson's disease (PD), and that in some patients, cognitive impairment occurs even at the time of diagnosis. The point prevalence of dementia in PD is close to 30% and the incidence rate is increased 4-6 times as compared to controls. The cumulative prevalence is very high, at least 75% of PD patients who survive for more than 10 years will develop dementia. The mean time from onset of PD to dementia is approximately 10 years. However, there are considerable variations, and some patients develop dementia early in the disease course. Earlier onset of dementia is associated with more structural brain changes. The most established risk factors for early dementia are old age, severity of motor symptoms, in particular postural and gait disturbances, mild cognitive impairment and visual hallucinations. The genetic contributions to dementia are currently not clear and need to be explored in future studies.
Similar articles
-
Cognitive dysfunction and dementia in Parkinson disease.Mov Disord. 2007 Sep;22 Suppl 17:S358-66. doi: 10.1002/mds.21677. Mov Disord. 2007. PMID: 18175397 Review.
-
Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.J Geriatr Psychiatry Neurol. 2010 Mar;23(1):27-34. doi: 10.1177/0891988709351833. Epub 2009 Dec 30. J Geriatr Psychiatry Neurol. 2010. PMID: 20042544
-
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.Mov Disord. 2008 Jul 30;23(10):1441-5. doi: 10.1002/mds.22126. Mov Disord. 2008. PMID: 18512749
-
Cognitive impairment and dementia in Parkinson's disease.Mov Disord. 2010;25 Suppl 1:S110-6. doi: 10.1002/mds.22787. Mov Disord. 2010. PMID: 20187235
-
[Dementia in Parkinson's disease].Tidsskr Nor Laegeforen. 2007 Oct 4;127(19):2517-20. Tidsskr Nor Laegeforen. 2007. PMID: 17925819 Review. Norwegian.
Cited by
-
Predictors of cognitive impairment in newly diagnosed Parkinson's disease with normal cognition at baseline: A 5-year cohort study.Front Aging Neurosci. 2023 Feb 28;15:1142558. doi: 10.3389/fnagi.2023.1142558. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36926634 Free PMC article.
-
Differential cognitive effects of unilateral left and right subthalamic nucleus deep brain stimulation for Parkinson disease.medRxiv. 2023 Mar 1:2023.02.27.23286478. doi: 10.1101/2023.02.27.23286478. Preprint. medRxiv. 2023. PMID: 36909562 Free PMC article.
-
Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson's.Neurol Sci. 2023 Mar 4. doi: 10.1007/s10072-023-06684-1. Online ahead of print. Neurol Sci. 2023. PMID: 36870001 Review.
-
Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson's Disease.Antioxidants (Basel). 2023 Feb 7;12(2):399. doi: 10.3390/antiox12020399. Antioxidants (Basel). 2023. PMID: 36829958 Free PMC article.
-
Neuroprosthetics: from sensorimotor to cognitive disorders.Commun Biol. 2023 Jan 6;6(1):14. doi: 10.1038/s42003-022-04390-w. Commun Biol. 2023. PMID: 36609559 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical